|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 39/395 | |||
| C07K 16/28 | |||
| A61P 37/06 |
| (11) | Number of the document | 1294391 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01942118.9 |
| Date of filing the European patent application | 2001-06-08 | |
| (97) | Date of publication of the European application | 2003-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/018619 |
| Date | 2001-06-08 |
| (87) | Number | WO 2001/095928 |
| Date | 2001-12-20 |
| (30) | Number | Date | Country code |
| 210671 P | 2000-06-09 | US |
| (72) |
TOWNSEND, Robert, M., US
TODDERUD, Charles, Gordon, US
PEACH, Robert, J., US
|
| (73) |
Bristol-Myers Squibb Company,
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (54) | COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION |
| COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION |